Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 6.95
+0.25 (3.73%)
At close: Apr 17, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 106.70 million as of April 17, 2025. Its market cap has increased by 39.19% in one year.
Market Cap
106.70M
Enterprise Value
100.61M
Revenue
14.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.95
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 115.59M to 106.70M, a decrease of -7.69%. That is a compound annual growth rate of -1.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 106.70M | 54.10% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 846.81B |
| Atlas Copco AB | 708.58B |
| AB Volvo | 514.62B |
| ASSA ABLOY AB | 312.46B |
| EQT AB | 302.24B |
| Skandinaviska Enskilda Banken AB | 293.49B |
| Telefonaktiebolaget LM Ericsson | 262.79B |
| Swedbank AB | 247.33B |